JP Morgan Cazenove disclosed Chemring Group PLC (LON:CHG), supporting its price target at 185.00GBX earlier today
- Updated: April 20, 2017
Reporting a potential downside of -0.08%, JP Morgan Cazenove hold steady the target of Chemring Group PLC (LON:CHG) at 185.00GBX
On 4/7/2017, Liberum Capital released a statement for Chemring Group PLC (LON:CHG) maintained the target price at 210.00GBX that suggested an upside of 0.10%.
Boasting a price of 201.63GBX, Chemring Group PLC (LON:CHG) traded -0.52% lower on the day. With the last stock price close up 10.26% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. Chemring Group PLC has recorded a 50-day average of 196.17GBX and a two hundred day average of 174.59GBX. Volume of trade was down over the average, with 9,905 shares of CHG changing hands under the typical 689,440
Chemring Group PLC has 52 week low of 90.25GBX and a 52 week high of 208.00GBX and has a market capitalization of 0 GBX.
Brief Synopsis On Chemring Group PLC (LON:CHG)
Chemring Group PLC is engaged in offering solutions to protect defense and security markets. The Company operates through three segments: Countermeasures, which is engaged in the development and manufacture of expendable countermeasures for air, sea and land platforms, and land-based electronic warfare equipment; Sensors & Electronics, which is engaged in the development and manufacture of improvised explosive device (IED) detection equipment, chemical and biological threat detection equipment, IED electronic countermeasures, network protection technologies and explosive ordnance disposal equipment, and Energetic Systems, which is engaged in the development, procurement and manufacture of signals and illumination devices and payloads, cartridge/propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile and ammunition components, propellants, warheads, fuses, separation sub-systems, actuators and energetic materials.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.